Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 14 of 15
Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Intervention
NCT01230606
A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)
NCT00580294
Mothers Avoiding Depression Through Empowerment Intervention Trial
NCT01312883
Research Tissue Bank
NCT00666549
Effects of Aerobic Exercise on Cognition, Mood and Fatigue Following TBI
NCT00619463
The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients
NCT00548639
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
NCT00488969
The Effect of Prophylactic Swallowing Exercises on Head and Neck Cancer Patients
NCT01349309
Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
NCT01103440
Natural History of Apparent Mineralocorticoid Excess Syndrome
NCT00474942
Correlative Biomarker Study in Patients With Myeloproliferative Disorders
NCT00665067
The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery
NCT00413244
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873
Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer
NCT00463060
Effects of Glycoxidative Stress on Human Aging
NCT00579774
Effectiveness of Trauma-Focused Cognitive Behavioral Therapy in Treating Children With Post-Traumatic Stress Disorder
NCT00614068
Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth
NCT00404911
Patient Centered Randomized Controlled Trial
NCT00233077
Improving Metabolic Control in Diabetic Young Children
NCT00439985
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
NCT00455143
Effects of HIV and Hepatitis C Virus on the Brain
NCT00494936
Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness
NCT00364910
The Role Of Omega-3 Fatty Acids In Adolescent Depression
NCT00962598
The Epidemiology of Ventricular Assist Device-Related Infections
NCT01471795
The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices
NCT01481012
Omega-3 Fatty Acids in Adolescent Depression
NCT00312897
Treatment of Post-TBI Depression
NCT00211835
Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program
NCT00233129
Topiramate in the Treatment of Pathological Gambling
NCT00245583
Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents
NCT00418977
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391
Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment
NCT00233090
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults
NCT00278473
Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism.
NCT00211770
Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism
NCT00211783
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
NCT00211822
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
NCT00158223
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
NCT00145197
Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
NCT00816127
Prediction of CK-MB Release During Otherwise Successful Stenting Procedure
NCT00489242
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103
Improving Hypertension Control in East and Central Harlem
NCT00211666
Elder Surgery - Functional Recovery Following Beta Blockade
NCT00507663
Preventing Recurrent Stroke in Minority Populations
NCT00211731
Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type
NCT00824317
Study of Fluoxetine in Adults With Autistic Disorder
NCT00027404
Improving Heart Failure Care in Minority Communities
NCT00211874
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix
NCT00005965
Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers
NCT00211848
Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
NCT00004480
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.